Literature DB >> 4912071

Significance of vibriocidal antibodies with regard to immunity to cholera.

E J Gangarosa, W E DeWitt, J C Feeley, M R Adams.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 4912071     DOI： 10.1093/infdis/121.supplement.s36

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.

Authors:  Ana A Weil; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Taher Uddin; Yasmin Ara Begum; Nirod Chandra Saha; Richelle C Charles; Regina C Larocque; Jason B Harris; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Am J Trop Med Hyg       Date:  2012-09-10       Impact factor: 2.345

2.  Report of the 1966-67 cholera vaccine trial in rural East Pakistan.

Authors:  W H Mosley; K M Aziz; A S Mizanur Rahman; A K Alauddin Chowdhury; A Ahmed; M Fahimuddin
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

3.  Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Authors:  C O Tacket; M B Cohen; S S Wasserman; G Losonsky; S Livio; K Kotloff; R Edelman; J B Kaper; S J Cryz; R A Giannella; G Schiff; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.